See also this year's filing and all EDGAR filings for this company.
PDF Report 0001269021_2020_PORTOLA_PHARMACEUTICALS_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001269021')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001269021, PORTOLA PHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 462,133,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 4,264,000 |
| 3 | remainder_Assets | 112,086,000 |
| 4 | LiabilitiesCurrent | 102,418,000 |
| 5 | LiabilitiesNoncurrent | 135,183,000 |
| 6 | remainder_Liabilities | 211,057,000 |
| 7 | CostOfGoodsAndServicesSold | 44,378,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 218,919,000 |
| 9 | ResearchAndDevelopmentExpense | 124,627,000 |
| 10 | remainder_Expenses | 31,290,000 |
| 11 | remainder_Revenues | 116,640,000 |
| 12 | remainder_NetIncome | 9,698,000 |
| 13 | remainder_ComprehensiveNetIncome | 2,531,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 578,483,000 |
| 1 | Liabilities | 448,658,000 |
| 2 | Expenses | 419,214,000 |
| 3 | Revenues | 116,640,000 |
| 4 | StockholdersEquity | 129,825,000 |
| 5 | NetIncome | -292,876,000 |
| 6 | ComprehensiveNetIncome | -291,610,500 |
| 7 | BaseVar | 787,612,000 |
| 8 | EconomicCapitalRatio | -0.133 |
Edgar->Model Mapping
Feature Distribution
Change over Time
